President Donald Trump is expected to announce Monday a possible link between Tylenol use and autism risk, according to The Washington Post — a claim likely to draw strong reaction from the medical community.

The reported warning will be part of what Trump called an "amazing" public health announcement at the White House. Health and Human Services Secretary Robert F. Kennedy Jr., a longtime critic of mainstream medical guidance, is expected to feature prominently in the event.

IN CASE YOU MISSED IT | HHS Secretary Kennedy targets causes of autism, report due next month

"I think it's going to be one of the most important news conferences I'll ever have and I look so forward to it," Trump said Sunday.

Trump discussed the upcoming announcement Sunday during a memorial for conservativ

See Full Page